Weight fluctuation was associated with a greater risk for diabetic kidney disease progression among individuals with type 1 diabetes.

Black Diamond Therapeutics presents a compelling investment opportunity with strong potential, balanced by inherent biotech ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Biosciences announced the presentation of preclinical data investigating the potential of co-administration of deoxyribonuclease ...

Circulating kidney injury molecule-1 (KIM-1) predicts survival outcomes in patients with metastatic renal cell carcinoma (mRCC), even in patients who have coexisting acute kidney injury (AKI) or ...

During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.

An Australian medical technology company, Proteomics International, has published a study demonstrating a new blood test ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

post-eGFR 13.8%, P = 0.001). The percentage of patients newly referred to a nephrologist during the study period was mildly higher when examining the CKD 4 subgroup (pre-eGFR 9.4% [n = 32] vs.

US Military's Largest Helicopter: The CH-53K King Stallion 13 Authentic Facts About Billy the Kid That Hollywood Often Overlooks NFL Kicking Legends: 25 Greatest Kickers Who Defined League History ...

Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC and petosemtamab monotherapy in ...